Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.

This was the stock's second consecutive day of gains.

A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience ...

For superior performance in quality, delivery, innovation and partnership related to fluid dispensing systems used in ...

Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.

Skyrocketing technology requirements for AI data centers is expected to drive market demand for Photonic Integrated Circuits ...

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...

Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...